Back to results
CompletedPhase 3

EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer

NCT00129935

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Hospital Arquitecto Marcide

Ferrol, A Coruña, Spain

+57 additional locations

View on ClinicalTrials.gov
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer — TrialFind